• Press Release

Diminished Activation of Specific Prefrontal Brain Region May Directly Contribute to Binge Eating in Bulimia Nervosa, New Study Reveals

Findings suggest this region as a promising treatment target

  • New York, NY
  • (February 25, 2022)

New research conducted by an investigator from the Icahn School of Medicine at Mount Sinai has revealed a key neural mechanism underlying the feeling of being unable to stop eating, the most salient aspect of binge episodes in eating disorders like bulimia nervosa.

The researcher found deficient activation of the medial and lateral prefrontal cortices (brain regions known to play a role in the control of cravings, behaviors, and emotions) during eating-specific response inhibition in participants with bulimia nervosa compared with healthy controls. The findings, published February 25 in Psychological Medicine, provide initial evidence that this dimished activation of the prefrontal cortex may directly contribute to more severe, out-of-control, maladaptive eating behaviorsThis supports the idea that medial and lateral prefrontal cortex dysfunction may be a promising treatment target.  

Bulimia nervosa is a serious, common psychiatric disorder that is associated with high rates of disability and mortality. Fewer than half of adults treated with first-line interventions recover. The neural bases of bulimia nervosa’s symptoms remain poorly understood, hindering efforts to develop more efficacious treatments. Decades of previous research suggest that the sense of a loss of control over eating is the most important feature of the binge eating that characterizes the disorder. Therefore, pinpointing the brain-based alterations that occur specifically during attempts to control eating could ultimately improve our understanding of, and targeted treatment for, this often chronic condition.

This study, led by Laura Berner, PhD, Assistant Professor of Psychiatry at Icahn Mount Sinai and a leading investigator in the Mount Sinai Center of Excellence in Eating and Weight Disorders and the Center for Computational Psychiatry, is the first to examine brain activation during attempts to control eating behavior in individuals with eating disorders.

Most studies of how we stop or prevent ourselves from engaging in a behavior ask people to perform a task that involves withholding button-pressing responses. But Dr. Berner developed a new task that asks people to withhold eating responses. Using a portable brain imaging technology called functional near-infrared spectroscopy (fNIRS), the research team measured activation of the prefrontal cortices of 23 women with bulimia nervosa (BN) and 23 healthy controls during this novel go/no-go task requiring inhibition of eating responses and during a standard go/no-go task requiring inhibition of button-pressing responses.

They found women with BN made commission errors on both tasks—they ate and pressed the button when they were not supposed to—more often than women without an eating disorder. Coupled with this reduced ability to control their eating responses, the subsets of women with BN who had the most severe sense of loss of control over their eating in the last month, and those who felt most strongly that they binge-ate during the task, both showed abnormally reduced bilateral ventromedial (vmPFC) and right ventrolateral prefrontal cortex (vlPFC) activation during eating-response inhibition. Similarly, in the entire sample, lower eating-task activation in right vlPFC was related to more frequent and severe loss-of-control eating, but no group differences in activation were detected on either task when this full sample was compared with healthy controls. Notably, BN diagnosis and severity were unrelated to brain activation during button-pressing inhibition.

“Our patients describe feeling like they just can’t stop themselves from taking that next bite or sip during binge-eating episodes, but we didn’t understand the neural mechanisms that might underlie that experience. For the first time, this method has allowed us to measure what is happening in the brains of people with bulimia nervosa when they are trying to inhibit their eating responses, but cannot,” said Dr. Berner. “Our findings suggest that eating-specific impairments in inhibitory control-related activation may serve as a new target for treatment. In fact, we just learned that we received funding from the National Eating Disorders Association to test this idea. We will be using fNIRS-based neurofeedback to train women with bulimia nervosa to increase their own prefrontal cortex activation while eating, and we’ll test how that training impacts symptoms.” 

Who:
Laura Berner, PhD, Assistant Professor of Psychiatry, Icahn Mount Sinai and a principal investigator for the Mount Sinai Center for Computational Psychiatry and the Mount Sinai Center of Excellence in Eating and Weight Disorders.

This work was supported by a National Institute of Mental Health fellowship (F31MH097406), an American Psychological Association Dissertation Research Award, and an Academy for Eating Disorders Student Research Grant awarded to Dr. Berner.

Article: Altered prefrontal activation during the inhibition of eating responses in women with bulimia nervosa. Psychological Medicine, February 25, 2022.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.